Scientific publications

Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans

V. Catalán [SP] (1,5), J. Gómez-Ambrosi [SP] (1,5), A. Rodríguez (1,5), B. Ramírez (1,5), C. Silva [SP] (2,5), F. Rotellar (3,5), M. J. Gil [SP] (4,5), J. A. Cienfuegos (3,5), J. Salvador (2,5) and G. Frühbeck [SP] (1,2,5) 
(1) Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain
(2) Department of Endocrinology, Clínica Universitaria de Navarra, University of Navarra, Avda. Pío XII, 36, Pamplona, 31008, Spain
(3) Department of Surgery, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain
(4) Department of Biochemistry, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain
(5) CIBER Fisiopatología de la Obesidad y Nutrición

Magazine: Journal of Molecular Medicine

Date: May 23, 2009

General and Digestive Surgery Biochemistry [SP] Endocrinology and Nutrition [SP]

Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation.

The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well as its involvement in inflammation.

VAT biopsies from 47 subjects were used in the study. Real-time PCR and Western-blot analyses were performed to quantify levels of LCN2 in VAT as well as the association with other genes implicated in inflammatory pathways. Forty-four serum samples were used to analyze the circulating concentrations of LCN2. Zymography analysis was used to determine the activity of matrix metalloproteinase (MMP) in VAT. Obese patients exhibited increased mRNA (p?<?0.0001) and protein (p?=?0.017) expression levels of LCN2 compared to lean subjects. Although no differences in plasma LCN2 concentrations were observed, increased circulating LCN2/MMP-9 complex levels were found (p?=?0.038) in the obese group. Moreover, obese individuals showed increased (p?<?0.01) activity of MMP-2 and MMP-9/LCN2 complex, while a positive correlation (p? <?0.01) between MMP-2 and MMP-9 activities and BMI was observed. Gene and protein expression levels of LCN2 in VAT were positively associated with inflammatory markers (p?<?0.01).

These findings represent the first observation that mRNA and protein levels of LCN2 are increased in human VAT of obese subjects. Furthermore, LCN2 is associated with MMP-2 and MMP-9 activities as well as with pro-inflammatory markers suggesting its potential involvement in the low-grade chronic inflammation accompanying obesity.

CITATION J Mol Med. 2009 Aug;87(8):803-13

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra